Obalon Therapetics (NASDAQ: OBLN) Interview with CEO and President Kelly Huang, PhD

Dr. Huang talks about the the first commercial use for Oblaon Nav and Touch, gives an in-depth look of how their technology works, and discusses key goals for the year.

THIS INTERVIEW HAS EXPIRED, PLEASE CHECK OUT OUR FEATURED INTERVIEW SECTION FOR OTHER EXCITING OPPORTUNITIES.

About The Wall Street Analyzer 1608 Articles
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.